Results 251 to 260 of about 3,095,271 (376)

Rapid resolution of erythema marginatum after icatibant in acquired angioedema [PDF]

, 2011
Broesby-Olsen, Sigurd, Bygum, Anette
core   +1 more source

Proteolytic inactivation of plasma C1- inhibitor in sepsis. [PDF]

, 1989
Jan H. Nuijens, A J Eerenberg-Belmer, C C Huijbregts, W. O. Schreuder, R. J. F. Felt‐Bersma, Jannie J. Abbink, L. G. Thijs, C. Erik Hack   +7 more
openalex   +1 more source

AI‐Directed 3D Printing of Hierarchical Polyurethane Foams

Advanced Science, EarlyView.
Digitally guided direct ink writing, combined with AI‐generated design, enables the fabrication of hierarchical polyurethane foams with tunable multiscale porosity. This approach produces architected foams featuring interconnected open‐cell networks and tailored mechanical properties, advancing the development of adaptive, high‐performance materials ...
Dhanush Patil, Jie Tian, Kun Jiang, Clarissa Westover, Sri Vaishnavi Thummalapalli, Arunachalam Ramanathan, Arpita Shome, Natalie Crutchfield, M. Taylor Sobczak, Sean Lee, Hongyue Sun, Elizabeth J. Brisbois, Hitesh Handa, Timothy E. Long, Xianqiao Wang, Kenan Song   +15 more
wiley   +1 more source

Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. [PDF]

Mol Immunol, 2022
Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M.   +4 more
europepmc   +1 more source

P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL.

, 2022
Esther C. W. de Boer, Marit Jalink, L. Delvasto-Nuñes, Elisabeth M. Meulenbroek, Inge O. Baas, Susanne R. Janssen, E. E. Dijkman, Kyra A. Gelderman, D. Wouters, Marije D. Engel, Masja de Haas, M.-J. Kersten, Ilse Jongerius, Sacha Zeerleder, Josephine M. I. Vos   +14 more
openalex   +1 more source

Discovery of SKP2‐Recruiting PROTACs for Target Protein Degradation

Advanced Science, EarlyView.
Based on the SKP2‐targeting ligand SL1, we designed non‐covalent PROTACs by linking it with the BRD4 inhibitor JQ1 and the AR antagonist AL through a linker. These PROTACs successfully induced the ubiquitination of BRD4 and AR, followed by proteasome‐mediated degradation.
Guanjun Dong, Aima Huang, Ziqing Zhao, Bikai Lai, Xin Pan, Huiyu Yang, Xiaohan Xu, Tianwei Wang, Fangchen Zhao, Zhimin Zhang, Yongbo Xue, Guanjun Deng, Wenbin Deng, Jianwei Chen   +13 more
wiley   +1 more source

<i>De Novo</i> or inherited: gonosomal mosaicism in hereditary angioedema due to C1 inhibitor deficiency. [PDF]

Front Immunol
Batlle-Masó L, Perurena-Prieto J, Viñas-Giménez L, Aguiló-Cucurull A, Fernández-Álvarez P, Gil-Serrano J, Guilarte M, Colobran R.   +7 more
europepmc   +1 more source

Presentation of an extraordinary colic: abdominal pain as the first and only utterance of an acquired C1-inhibitor deficiency. [PDF]

BMJ Case Rep, 2022
Hanevelt J, de Vos Tot Nederveen Cappel WH.   +1 more
europepmc   +1 more source

PRDM1+ Malignant Cells Mediate an Immunosuppressive Landscape and Resistance to Neoadjuvant Chemoradiotherapy and Immunotherapy in Esophageal Squamous Cell Carcinoma

Advanced Science, EarlyView.
Integrated scRNA‐seq, scTCR‐seq analysis, and functional assays identify PRDM1+ malignant epithelial cells with hyper lipid peroxidation characteristics that demonstrate reduced responsiveness to the nICRT treatment. Principal factor PRDM1 activates cysteine metabolism genes to modulate lipid peroxidation (an intrinsic cellular pathway related to ...
Dijian Shen, Rui Li, Yong She, Xuefei Liu, Yuanyang Huang, Yongling Ji, Keying Chen, Zhengbo Song, Runzhe Chen, Xuan Li, Qi Zhao, Qixun Chen, Ming Chen   +12 more
wiley   +1 more source

Hereditary angioedema due to C1-inhibitor deficiency: current therapeutic approaches. [PDF]

Curr Opin Allergy Clin Immunol
Costanzo G, Sambugaro G, Firinu D.
europepmc   +1 more source